Skip to main content
SSY Group Limited logo

SSY Group Limited — Investor Relations & Filings

Ticker · 2005 ISIN · KYG8406X1034 HKEX Manufacturing
Open in API
Filings indexed 1,215 across all filing types
Latest filing 2021-08-27 Board/Management Inform…
Country HK Hong Kong
Listing HKEX 2005

About SSY Group Limited

http://www.ssygroup.com.hk

SSY Group Limited is an investment holding company specializing in the research, development, manufacturing, and sale of pharmaceutical products. The Group is a prominent manufacturer, with a core focus on producing a wide range of intravenous infusion solutions and finished drugs. Complementing its pharmaceutical offerings, the company also manufactures essential packaging materials, including non-PVC soft bags and PP plastic containers. SSY Group supplies its comprehensive product line, which often utilizes green production technologies aimed at reducing costs and power consumption, primarily to hospitals and medical institutions.

Recent filings

Filing Released Lang Actions
List of Directors and their Role and Function
Board/Management Information Classification · 95% confidence The document lists the members of the board of directors, their roles, and committee memberships as of a specific date. It focuses on board composition and governance structure rather than financial data, earnings, or shareholder votes. There is no indication of financial results, audit opinions, or meeting materials. This type of information aligns with announcements about board or management changes or details. Therefore, the document fits best under Board/Management Information (MANG). The document length is short and contains no report attachments or certifications, so it is not a report publication or regulatory filing.
2021-08-27 English
APPOINTMENT AND RESIGNATION OF EXECUTIVE DIRECTORS
Board/Management Information Classification · 100% confidence The document is an announcement from a company listed on the Hong Kong Stock Exchange regarding changes in its executive directors. It details the appointment of two new executive directors and the resignation of one executive director, including their biographical information, terms of service, and related disclosures. There is no financial data, earnings information, or report publication mentioned. The content focuses solely on board and management changes, which aligns with the category for announcements about changes in the company's board of directors or senior management.
2021-08-27 English
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2021
Interim / Quarterly Report Classification · 100% confidence The document is titled 'ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2021' and contains detailed financial and operational data for the six-month period ending June 30, 2021. It includes revenue figures, profit margins, business review, product sales, and R&D updates. The length is substantial (15,000 characters), and it contains substantive financial data and analysis, not just a brief announcement or a link to a report. The content matches the characteristics of an Interim / Quarterly Report, which provides comprehensive financial results for a period shorter than a full fiscal year. Therefore, the appropriate classification is Interim / Quarterly Report (IR). H1 2021
2021-08-27 English
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by the board of directors regarding the approval of a product (Blonanserin) by a regulatory authority in China. It is an update on product development and does not contain financial data, regulatory certifications, or meeting materials. The document is short (1652 characters) and serves to inform shareholders and investors about business progress rather than financial results or governance changes. It is not an annual or interim report, earnings release, or management discussion. It is also not a regulatory filing or legal proceeding. The best fitting category is a general regulatory announcement or miscellaneous update, which falls under Regulatory Filings (RNS).
2021-08-25 English
DATE OF BOARD MEETING
Report Publication Announcement Classification · 95% confidence The document is a short announcement from SSY Group Limited regarding the date of a Board meeting to approve the unaudited interim results for the six months ended 30 June 2021 and to consider an interim dividend. It does not contain any financial data or the actual interim report itself, but rather informs about the upcoming board meeting and the intention to publish the interim results. The document length is only 1407 characters, which is quite short and fits the pattern of an announcement rather than a full report. According to the rules, such announcements about report publication or board meeting dates are classified as Report Publication Announcements (RPA).
2021-08-17 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings Classification · 95% confidence The document is a monthly return report submitted to the Hong Kong Exchanges and Clearing Limited regarding movements in securities for SSY Group Limited for the month ended 31 July 2021. It details movements in authorized and issued share capital, share options, and confirmations related to securities issuance. The document is regulatory in nature, providing compliance information about share capital changes and confirmations required by the exchange listing rules. It does not contain financial statements, earnings data, or management discussion. It is not an announcement of a report publication but a regulatory filing itself. Therefore, it fits best under the category of Regulatory Filings (RNS).
2021-08-02 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.